Why Subscribe?
Select your subscription type:
Individuals will get:
- My weekly Edge column. TR anticipates trends and spots patterns ahead of the pack to give you an informational advantage. The Edge runs Mondays. Sample headlines here, here, and here.
- My Frontpoints week in review. TR makes sure you don’t miss the most important news, deals, and shenanigans–with a dash of context and commentary. Frontpoints runs Fridays. Sample headlines here, here, and here.
- In-depth reports on the scientific, medical, financial & political aspects of industry, from an integrative thinker with 15 years covering the industry. Reports run regularly. Sample headlines here, here, and here.
- No ads. I won’t sell your data, and I won’t waste your time.
- Elite readers. Join a community of biotech’s leading thinkers and doers.
Over time, TR will help you find your next partner, next investment opportunity, or next job.
Corporate site license
Companies can get a 10% discount off the regular rate of $149 per person per year by purchasing a group of subscriptions. Get one easy payment and one shared company login.
Pricing:
Company size | Estimated # of readers | Price |
50 employees or less | 5 | $670 |
50-500 employees | 15 | $2,000 |
500-5,000 employees | 35 | $4,700 |
5000+ employees | 100 | $13,400 |
Individual subscriptions cannot be shared; that is a copyright violation. By purchasing a corporate license, you obtain the right to share Timmerman Report content internally. You also can request a free PDF of a story you’d like to post on your internal website.
To purchase a bulk subscription, e-mail me at luke@timmermanreport.com.